FindTrial
Sign In

Status survey of endocrinological complications of thalassemia major in Guangdong and Guangxi Province, and a multicenter prospective nested case-control study on risk factors of abnormal glucose metabolism in those patients

Status survey of endocrinological complications of thalassemia major in Guangdong and Guangxi Province, and a multicenter prospective nested case-control study on risk factors of abnormal glucose metabolism in those patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016333
Enrollment
Unknown
Registered
2018-05-25
Start date
2018-05-17
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thalassemia major

Interventions

Case series:Nil

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Confirmed diagnosis base on hemotological and genetic criteria; willing and capable to cooperate with scheduled treatment, lab tests/imaging and follow up

Exclusion criteria

Exclusion criteria: non-trasfusion dependent thalassemia; complicated with malignancy; HIV and/or HCV tests positive; incomplete clinical/lab data; status post stem cell transplantation

Design outcomes

Primary

MeasureTime frame
serum ferritin;serum iron;TSH;FT3;FT4;ACTH;cortisol;PTH;serum calcium;Serum phosphate;ALP;25-(OH) Vitamin D;serum glucose;serum insulin;C-Peptide;GHb;HCV Ab;HIV Ab;Temperature;Heart Rate;Repiratory rate;blood pressure;height;Weight;waist/abdominal circumference;Tanner Stage;BMI;Heart, liver and pancreas MRI;CBC;—

Secondary

MeasureTime frame
FSH;LH;T;E2;—

Countries

China

Contacts

Public ContactLIANG Liyang

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

doctorlly@126.com+86 20 34071030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026